TATA Health International (HKG:1255) reported HK$20.6 million in attributable profit for the first half of 2025, swinging from a loss of HK$5.1 million a year earlier, according to a Hong Kong bourse filing Sunday.
Earnings per share was HK$0.08, compared with a loss of HK$0.02 in the prior year.
The footwear company's revenue fell 42% year-on-year to HK$42.1 million, figures showed.
Shares of the company remain suspended from trading.